Windlas Biotech Q4 Results Live : profit rise by 48.49% YOY
Windlas Biotech Q4 Results Live : Revenue increased by 21.73% YoY & profit increased by 48.49% YoY
Windlas Biotech Q4 Results Live : Windlas Biotech declared their Q4 results on 20 May, 2024. The topline increased by 21.73% & the profit increased by 48.49% YoY. Compared to the previous quarter, the revenue grew by 5.59% and the profit increased by 12.55%.
The Selling, general & administrative expenses rose by 0.52% q-o-q & increased by 25.34% Y-o-Y.
The operating income was up by 8.97% q-o-q & increased by 43.48% Y-o-Y.
The EPS is ₹8.14 for Q4 which increased by 51.25% Y-o-Y.
Windlas Biotech has delivered 13.43% return in the last 1 week, 40% return in the last 6 months, and 41.8% YTD return.
Currently, Windlas Biotech has a market cap of ₹1264.45 Cr and a 52wk high/low of ₹648 & ₹260.1 respectively.
Windlas Biotech Financials
| Period | Q4 | Q3 | Q-o-Q Growth | Q4 | Y-o-Y Growth |
|---|---|---|---|---|---|
| Total Revenue | 171.28 | 162.21 | +5.59% | 140.71 | +21.73% |
| Selling/ General/ Admin Expenses Total | 22.85 | 22.73 | +0.52% | 18.23 | +25.34% |
| Depreciation/ Amortization | 3.54 | 3.39 | +4.34% | 3.57 | -0.9% |
| Total Operating Expense | 152.82 | 145.27 | +5.2% | 127.84 | +19.54% |
| Operating Income | 18.47 | 16.95 | +8.97% | 12.87 | +43.48% |
| Net Income Before Taxes | 22.63 | 19.81 | +14.26% | 15.04 | +50.47% |
| Net Income | 16.99 | 15.1 | +12.55% | 11.44 | +48.49% |
| Diluted Normalized EPS | 8.14 | 7.26 | +12.12% | 5.38 | +51.25% |
Catch all the Business News , Corporate news , Breaking News Events and Latest News Updates on Live Mint. Download The Mint News App to get Daily Market Updates.